Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Follow-up data reported for Amelorad

Feb. 7, 1997

Merck describes improved chemotherapeutic agents

Feb. 7, 1997

Whole-body hyperthermia therapy enters clinic for new indication

Feb. 6, 1997

Sugen's TK antagonist enters phase II

Feb. 6, 1997

Antitumor prodrugs for ADEPT from Pharmachemie

Feb. 6, 1997

ChiRex and Cell Therapeutics sign supply agreement

Feb. 5, 1997

GeneMedicine IND approved

Feb. 4, 1997

Demeter receives funding for anticancer program

Feb. 4, 1997

Antineoplastic antibiotics isolated by Japanese investigators

Feb. 4, 1997

Merck & Co. continues to develop farnesyl protein transferase inhibitors

Feb. 4, 1997

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...